Fair Value Calculator Fair Value Calculator
EN DE

NeuRizer Ltd (NRZ) Fair Value & Analysis

Basic Materials · AU · Market cap A$3.4M

NL NeuRizer Ltd NRZ · AU
PriceA$0.0010
Fair ValueA$0.0010
Upside-0.1%
Quality37/100
Watch NeuRizer Ltd for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range A$0.0010 – A$0.0010

Fair value as of: Jun 26, 2026

From 3 valuation models · updated 7 days ago

Fair value updated Jun 26, 2026 — revised from A$0.0400 to A$0.0010 (−97.5%) since Jun 24, 2026.

Price vs Fair Value (12 months)

A$0.0010 A$0.0010 Fair Value A$0.0010 Jun 2025 Jul 2026

12‑month range A$0.0010 – A$0.0010 · fair‑value band A$0.0010 – A$0.0010 · the A$0.0010 price screens above the A$0.0010 fair value. As of Jun 26, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

NeuRizer Ltd (NRZ) currently trades at A$0.0010, while our model-based Fair Value estimate is A$0.0010 — implying the stock looks roughly 0.1% overvalued today. We read business quality at 37/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

It earns a return on equity of -10.7%. Net debt stands at A$1.5M. Fundamentals as of Jun 26, 2026

Key figures & financial health

Return on equity -10.7%
Free cash flow −A$6.1M FY2024
Net debt A$1.5M FY2024

Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.

About the company

NeuRizer Ltd. manufactures and sells urea fertilizers in Australia. It operates NeuRizer Urea project that deliver nitrogen-based fertilizers for agricultural markets. The company was formerly known as Leigh Creek Energy Limited and changed its name to NeuRizer Ltd. in March 2022. NeuRizer Ltd. is based in Adelaide, Australia.

Revenue & earnings trend

FY2019 – FY2024 · reported fiscal years

NeuRizer Ltd reported revenue of A$7.2K in FY2023 versus A$124K in FY2019, a compound −51.0%/yr. Reported net income was −A$5.6M in FY2024.

Revenue −51.0%/yr
FY19 A$124K
FY20 A$25.5K
FY21 A$2.6K
FY22 A$1.8K
FY23 A$7.2K
Net income
FY20 −A$7.2M
FY21 −A$13.6M
FY22 −A$20.4M
FY23 −A$16.3M
FY24 −A$5.6M

Is NRZ fairly valued? → Check now

Similar stocks

6 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $78.86 $41.93 -47%
Nutrien Ltd NTR $68.50 $52.75 -23%
Qinghai Salt Lake Industry Co 000792 ¥29.03 ¥21.15 -27%
CF Industries Holdings C1FI34 R$627.77 R$947.15 +51%
Yara International ASA YAR kr 433.40 kr 67.25 -84%
ICL Group ICL $5.07 $2.88 -43%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is NeuRizer Ltd (NRZ) undervalued?
As of Jun 26, 2026, our model estimates a fair value of A$0.0010 versus a price of A$0.0010 — about −0% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NRZ?
Our model-based fair value for NeuRizer Ltd is A$0.0010 (as of Jun 26, 2026), built from audited fundamentals. The current price is A$0.0010.
What is the quality score of NRZ?
NeuRizer Ltd has a Quality Score of 37/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the net profit margin of NRZ?
The net profit margin of NeuRizer Ltd is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.